NO820371L - Fremgangsmaate for fremstilling av pirbuterol og analoger derav - Google Patents
Fremgangsmaate for fremstilling av pirbuterol og analoger deravInfo
- Publication number
- NO820371L NO820371L NO820371A NO820371A NO820371L NO 820371 L NO820371 L NO 820371L NO 820371 A NO820371 A NO 820371A NO 820371 A NO820371 A NO 820371A NO 820371 L NO820371 L NO 820371L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- compound
- hydrogenation
- hydrogen
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title abstract description 6
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 claims abstract description 31
- 229960005414 pirbuterol Drugs 0.000 claims abstract description 30
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 26
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims abstract description 24
- -1 methylphosphonium halide Chemical class 0.000 claims abstract description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 23
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 22
- 239000001257 hydrogen Substances 0.000 claims abstract description 22
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 21
- 238000003797 solvolysis reaction Methods 0.000 claims abstract description 17
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000001412 amines Chemical class 0.000 claims abstract description 14
- 150000002118 epoxides Chemical class 0.000 claims abstract description 12
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract description 7
- 150000004965 peroxy acids Chemical class 0.000 claims abstract description 7
- DLSOILHAKCBARI-UHFFFAOYSA-N n-benzyl-2-methylpropan-2-amine Chemical compound CC(C)(C)NCC1=CC=CC=C1 DLSOILHAKCBARI-UHFFFAOYSA-N 0.000 claims abstract description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000002431 hydrogen Chemical group 0.000 claims description 5
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 23
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 12
- 238000010438 heat treatment Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 8
- 150000001204 N-oxides Chemical class 0.000 abstract description 3
- 239000000543 intermediate Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 29
- 238000010992 reflux Methods 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000003054 catalyst Substances 0.000 description 15
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- 239000011541 reaction mixture Substances 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Chemical group 0.000 description 4
- ZRTGPQQPNAEINU-UHFFFAOYSA-N 1-oxido-2-(oxiran-2-yl)-5-phenylmethoxypyridin-1-ium Chemical compound C=1C=C(C2OC2)[N+]([O-])=CC=1OCC1=CC=CC=C1 ZRTGPQQPNAEINU-UHFFFAOYSA-N 0.000 description 3
- MLMBUIFKAVTPJM-UHFFFAOYSA-N 2-ethenyl-5-phenylmethoxypyridine Chemical compound C1=NC(C=C)=CC=C1OCC1=CC=CC=C1 MLMBUIFKAVTPJM-UHFFFAOYSA-N 0.000 description 3
- VJUQZQITTGYEQP-UHFFFAOYSA-N 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-methylpyridin-3-ol;dihydrochloride Chemical compound Cl.Cl.CC1=NC(C(O)CNC(C)(C)C)=CC=C1O VJUQZQITTGYEQP-UHFFFAOYSA-N 0.000 description 3
- IJAKLEKTAIWJTA-UHFFFAOYSA-N 6-[2-(tert-butylamino)-1-hydroxyethyl]pyridin-3-ol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C=N1 IJAKLEKTAIWJTA-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 3
- 238000006640 acetylation reaction Methods 0.000 description 3
- 150000001414 amino alcohols Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VEWMLSSPWCVTLG-UHFFFAOYSA-N 2-(oxiran-2-yl)-5-phenylmethoxypyridine Chemical compound C=1C=CC=CC=1COC(C=N1)=CC=C1C1CO1 VEWMLSSPWCVTLG-UHFFFAOYSA-N 0.000 description 2
- ZWVGUDKESHNZDS-UHFFFAOYSA-N 2-(tert-butylamino)-1-(1-oxido-5-phenylmethoxypyridin-1-ium-2-yl)ethanol Chemical compound C1=[N+]([O-])C(C(O)CNC(C)(C)C)=CC=C1OCC1=CC=CC=C1 ZWVGUDKESHNZDS-UHFFFAOYSA-N 0.000 description 2
- ZVJVOAKDRAOECT-UHFFFAOYSA-N 2-(tert-butylamino)-1-(5-phenylmethoxypyridin-2-yl)ethanol Chemical compound C1=NC(C(O)CNC(C)(C)C)=CC=C1OCC1=CC=CC=C1 ZVJVOAKDRAOECT-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- DBGGDAAQLLDHSS-UHFFFAOYSA-N 5-phenylmethoxypyridine-2-carbaldehyde Chemical compound C1=NC(C=O)=CC=C1OCC1=CC=CC=C1 DBGGDAAQLLDHSS-UHFFFAOYSA-N 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
- POQMNSYPGJZIKT-UHFFFAOYSA-N 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)-1-oxidopyridin-1-ium-3-ol;dihydrochloride Chemical compound Cl.Cl.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=[N+]1[O-] POQMNSYPGJZIKT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000000397 acetylating effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008098 formaldehyde solution Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000007031 hydroxymethylation reaction Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- KEYZUMLVDCHSTP-UHFFFAOYSA-N pyridin-2-ylmethyl acetate Chemical compound CC(=O)OCC1=CC=CC=N1 KEYZUMLVDCHSTP-UHFFFAOYSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- NPGSNHCTEMFXEJ-UHFFFAOYSA-N 1-oxido-2-(oxiran-2-yl)pyridin-1-ium Chemical compound [O-][N+]1=CC=CC=C1C1OC1 NPGSNHCTEMFXEJ-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- DVZRYTWXFWRYPT-UHFFFAOYSA-N 2-(oxiran-2-yl)pyridine Chemical compound C1OC1C1=CC=CC=N1 DVZRYTWXFWRYPT-UHFFFAOYSA-N 0.000 description 1
- IRAQLKNWLCFQRC-UHFFFAOYSA-N 2-[benzyl(tert-butyl)amino]-1-pyridin-2-ylethanol Chemical compound C=1C=CC=CC=1CN(C(C)(C)C)CC(O)C1=CC=CC=N1 IRAQLKNWLCFQRC-UHFFFAOYSA-N 0.000 description 1
- RBYURGMHFCPCNY-UHFFFAOYSA-N 6-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)pyridin-3-ol Chemical compound NCC(O)C1=CC=C(O)C(CO)=N1 RBYURGMHFCPCNY-UHFFFAOYSA-N 0.000 description 1
- RJECIBXEHNDMFV-UHFFFAOYSA-N 6-[2-[benzyl(tert-butyl)amino]-1-hydroxyethyl]-2-(2-hydroxyethyl)pyridin-3-ol;dihydrochloride Chemical compound Cl.Cl.C=1C=CC=CC=1CN(C(C)(C)C)CC(O)C1=CC=C(O)C(CCO)=N1 RJECIBXEHNDMFV-UHFFFAOYSA-N 0.000 description 1
- NODCOHADVRTFPY-UHFFFAOYSA-N 6-[2-[benzyl(tert-butyl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol;dihydrochloride Chemical compound Cl.Cl.C=1C=CC=CC=1CN(C(C)(C)C)CC(O)C1=CC=C(O)C(CO)=N1 NODCOHADVRTFPY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 125000000815 N-oxide group Chemical group 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- JNMIXMFEVJHFNY-UHFFFAOYSA-M methyl(triphenyl)phosphanium;iodide Chemical compound [I-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 JNMIXMFEVJHFNY-UHFFFAOYSA-M 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- VFJYIHQDILEQNR-UHFFFAOYSA-M trimethylsulfanium;iodide Chemical compound [I-].C[S+](C)C VFJYIHQDILEQNR-UHFFFAOYSA-M 0.000 description 1
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23292381A | 1981-02-09 | 1981-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO820371L true NO820371L (no) | 1982-08-10 |
Family
ID=22875140
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO820371A NO820371L (no) | 1981-02-09 | 1982-02-08 | Fremgangsmaate for fremstilling av pirbuterol og analoger derav |
NO824274A NO824274L (no) | 1981-02-09 | 1982-12-20 | 2-acetoksymetyl-6-(1-acetoksy-2-(n-t-butylacetamid)-etyl) -pyridin-derivater og fremgangsmaate for fremstilling og anvendelse derav |
NO824275A NO824275L (no) | 1981-02-09 | 1982-12-20 | 6-(1-hydroksy-2(n-t-butylbenzylamino)etyl) pyridin-derivater og fremgangsmaate for fremstilling og anvendelse derav |
NO824273A NO824273L (no) | 1981-02-09 | 1982-12-20 | 6-(1-hydroksy-2-t-butylaminp-etyl)-pyridin-n-oksyd-derivater og fremgangsmaate for fremstilling og anvendelse derav |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO824274A NO824274L (no) | 1981-02-09 | 1982-12-20 | 2-acetoksymetyl-6-(1-acetoksy-2-(n-t-butylacetamid)-etyl) -pyridin-derivater og fremgangsmaate for fremstilling og anvendelse derav |
NO824275A NO824275L (no) | 1981-02-09 | 1982-12-20 | 6-(1-hydroksy-2(n-t-butylbenzylamino)etyl) pyridin-derivater og fremgangsmaate for fremstilling og anvendelse derav |
NO824273A NO824273L (no) | 1981-02-09 | 1982-12-20 | 6-(1-hydroksy-2-t-butylaminp-etyl)-pyridin-n-oksyd-derivater og fremgangsmaate for fremstilling og anvendelse derav |
Country Status (26)
Country | Link |
---|---|
EP (4) | EP0058071B1 (pt) |
JP (4) | JPS57150665A (pt) |
KR (1) | KR860000623B1 (pt) |
AR (4) | AR231439A1 (pt) |
AT (2) | ATE20882T1 (pt) |
AU (1) | AU530826B2 (pt) |
CA (1) | CA1179677A (pt) |
CS (1) | CS229678B2 (pt) |
DD (2) | DD210034A5 (pt) |
DE (2) | DE3272793D1 (pt) |
DK (1) | DK157541C (pt) |
EG (1) | EG16242A (pt) |
ES (4) | ES509430A0 (pt) |
FI (1) | FI820396L (pt) |
GR (1) | GR75867B (pt) |
GT (1) | GT198273686A (pt) |
IE (2) | IE52326B1 (pt) |
IL (1) | IL64954A (pt) |
NO (4) | NO820371L (pt) |
NZ (1) | NZ199646A (pt) |
PH (4) | PH20622A (pt) |
PL (4) | PL130917B1 (pt) |
PT (1) | PT74397B (pt) |
SU (4) | SU1194273A3 (pt) |
YU (3) | YU42756B (pt) |
ZA (1) | ZA82778B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3615293A1 (de) * | 1986-05-06 | 1987-11-12 | Bayer Ag | Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3700681A (en) * | 1971-02-16 | 1972-10-24 | Pfizer | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines |
BE795937A (fr) * | 1972-03-01 | 1973-08-27 | Pepro | Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee |
AR207639A1 (es) * | 1973-12-26 | 1976-10-22 | Pfizer | Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica |
US4031108A (en) * | 1974-10-09 | 1977-06-21 | Pfizer Inc. | 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane |
US3952101A (en) * | 1975-04-14 | 1976-04-20 | Smithkline Corporation | α-Amino methyl-5-hydroxy-2-pyridinemethanols |
-
1982
- 1982-02-03 SU SU823392299A patent/SU1194273A3/ru active
- 1982-02-04 NZ NZ199646A patent/NZ199646A/en unknown
- 1982-02-04 CS CS82781A patent/CS229678B2/cs unknown
- 1982-02-05 GT GT198273686A patent/GT198273686A/es unknown
- 1982-02-05 AR AR288347A patent/AR231439A1/es active
- 1982-02-05 GR GR67223A patent/GR75867B/el unknown
- 1982-02-08 EP EP82300604A patent/EP0058071B1/en not_active Expired
- 1982-02-08 DD DD82253605A patent/DD210034A5/de unknown
- 1982-02-08 DE DE8282300602T patent/DE3272793D1/de not_active Expired
- 1982-02-08 YU YU266/82A patent/YU42756B/xx unknown
- 1982-02-08 ES ES509430A patent/ES509430A0/es active Granted
- 1982-02-08 PT PT74397A patent/PT74397B/pt unknown
- 1982-02-08 IE IE275/82A patent/IE52326B1/en not_active IP Right Cessation
- 1982-02-08 EP EP82300603A patent/EP0058070A3/en not_active Withdrawn
- 1982-02-08 AT AT82300604T patent/ATE20882T1/de active
- 1982-02-08 DD DD82237264A patent/DD202544A5/de not_active IP Right Cessation
- 1982-02-08 CA CA000395768A patent/CA1179677A/en not_active Expired
- 1982-02-08 DK DK052182A patent/DK157541C/da not_active IP Right Cessation
- 1982-02-08 AT AT82300602T patent/ATE21691T1/de active
- 1982-02-08 AU AU80271/82A patent/AU530826B2/en not_active Expired
- 1982-02-08 DE DE8282300604T patent/DE3272061D1/de not_active Expired
- 1982-02-08 JP JP57018693A patent/JPS57150665A/ja active Granted
- 1982-02-08 EP EP82300602A patent/EP0058069B1/en not_active Expired
- 1982-02-08 IE IE273/82A patent/IE52325B1/en not_active IP Right Cessation
- 1982-02-08 NO NO820371A patent/NO820371L/no unknown
- 1982-02-08 KR KR8200528A patent/KR860000623B1/ko active
- 1982-02-08 ZA ZA82778A patent/ZA82778B/xx unknown
- 1982-02-08 EP EP82300605A patent/EP0058072A3/en not_active Withdrawn
- 1982-02-08 FI FI820396A patent/FI820396L/fi not_active Application Discontinuation
- 1982-02-09 PL PL1982239427A patent/PL130917B1/pl unknown
- 1982-02-09 PL PL1982239426A patent/PL130678B1/pl unknown
- 1982-02-09 PH PH26843A patent/PH20622A/en unknown
- 1982-02-09 EG EG60/82A patent/EG16242A/xx active
- 1982-02-09 PL PL1982235000A patent/PL130580B1/pl unknown
- 1982-02-09 PL PL1982239428A patent/PL130918B1/pl unknown
- 1982-02-09 IL IL64954A patent/IL64954A/xx active IP Right Revival
- 1982-11-17 AR AR291329A patent/AR229712A1/es active
- 1982-11-17 AR AR291328A patent/AR229374A1/es active
- 1982-11-17 AR AR291327A patent/AR229373A1/es active
- 1982-12-20 NO NO824274A patent/NO824274L/no unknown
- 1982-12-20 NO NO824275A patent/NO824275L/no unknown
- 1982-12-20 NO NO824273A patent/NO824273L/no unknown
-
1983
- 1983-01-05 SU SU833535711A patent/SU1217253A3/ru active
- 1983-01-05 SU SU833534107A patent/SU1240354A3/ru active
- 1983-01-05 SU SU833534854A patent/SU1250170A3/ru active
- 1983-01-13 ES ES518971A patent/ES518971A0/es active Granted
- 1983-01-13 ES ES518972A patent/ES518972A0/es active Granted
- 1983-01-13 ES ES518973A patent/ES8403112A1/es not_active Expired
- 1983-10-19 PH PH29714A patent/PH19164A/en unknown
- 1983-10-19 PH PH29713A patent/PH19167A/en unknown
- 1983-10-19 PH PH29712A patent/PH20292A/en unknown
-
1984
- 1984-11-28 YU YU2018/84A patent/YU43389B/xx unknown
- 1984-11-28 YU YU2019/84A patent/YU42908B/xx unknown
-
1985
- 1985-01-23 JP JP60010723A patent/JPS6059911B2/ja not_active Expired
- 1985-01-23 JP JP60010724A patent/JPS6059231B2/ja not_active Expired
- 1985-10-09 JP JP60225922A patent/JPS6193164A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100742482B1 (ko) | 피리딘-1-옥시드 유도체 및 이의 약제학적으로 유효한화합물로의 변환방법 | |
KR20050019919A (ko) | 5-(2'-피리딜)-2-피리돈 유도체의 제조 방법 | |
CS226444B2 (en) | Method of preparing 2,3-dichloro-5-trichloromethylpyridine | |
US6590099B2 (en) | Synthesis of heteroarylamine intermediate compounds | |
KR20180116371A (ko) | 4-알콕시-3-히드록시피콜린산의 제조 방법 | |
NO820371L (no) | Fremgangsmaate for fremstilling av pirbuterol og analoger derav | |
US6043371A (en) | Organic compound synthesis | |
WO1989006230A1 (en) | Cyano-dienes, halopyridines, intermediates and a process for their preparation | |
NO312027B1 (no) | Fremgangsmåte for fremstilling av O-(3-amino-2- hydroksypropyl)-hydroksiminsyrehalogenider | |
US4632992A (en) | Intermediates for preparing pirbuterol and analogs | |
US4477671A (en) | 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates | |
KR860000624B1 (ko) | 피르부테롤의 제조 방법 | |
JP3029901B2 (ja) | 新規なメトキシ基導入法による2−ヒドロキシメチル−4−メトキシ−3,5−ジメチルピリジンの製造法 | |
KR860000625B1 (ko) | 피르부테롤 및 그의 유도체의 제조 방법 | |
US6822093B2 (en) | Synthesis of heteroarylamine intermediate compounds | |
MXPA02007060A (es) | Procedimiento para la obtencion de compuestos heterociclicos. | |
HU205075B (en) | Process for producing substituted vinyl pyridines | |
JPH02117630A (ja) | ハロゲン化エチルベンゼンの製造法 | |
EP0383613A2 (en) | Optically active lactate, derivatives thereof and processes of producing same | |
JPH0543549A (ja) | αークロロシアノピリジン類の製造法 | |
CS229698B2 (cs) | Způsob výroby pirbuternlu a jeho analogů | |
JPS6124392B2 (pt) | ||
AU2946889A (en) | Cyano-dienes, halopyridines, intermediates and a process for their preparation | |
CS218536B1 (cs) | Způsob přípravy D-6-methyl-8/H2-kyanethyl)ergolinu-I |